| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,595 |
2,458 |
$168K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,064 |
2,579 |
$155K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,134 |
1,966 |
$95K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,836 |
2,662 |
$93K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
658 |
561 |
$49K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,595 |
2,458 |
$42K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
562 |
551 |
$16K |
| 87428 |
|
389 |
368 |
$10K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
541 |
506 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
421 |
355 |
$4K |
| 90686 |
|
124 |
120 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
138 |
133 |
$2K |
| 99000 |
|
296 |
290 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
66 |
33 |
$631.34 |
| 90756 |
|
22 |
19 |
$512.00 |
| 90674 |
|
13 |
12 |
$288.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15 |
15 |
$200.72 |
| A9150 |
Non-prescription drugs |
84 |
48 |
$0.00 |
| H0033 |
Oral medication administration, direct observation |
230 |
155 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
172 |
167 |
$0.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
14 |
13 |
$0.00 |